Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIB.
D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D002374:Catalase / Q000378:metabolism*; D003593:Cytoplasm / Q000187:drug effects; D003594:Cytoplasmic Granules; D005260:Female; D008099:Liver / Q000166:cytology / Q000201:enzymology*; D008297:Male; D008661:Metabolism, Inborn Errors / Q000188:drug therapy*; D051379:Mice; D009154:Mutation; D010544:Peroxidases / Q000378:metabolism; D012737:Sex Factors
D000924:Anticholesteremic Agents; D002087:Butyrates; D010544:Peroxidases; D002374:Catalase